Skip to main content
iScience logoLink to iScience
. 2024 Apr 25;27(5):109786. doi: 10.1016/j.isci.2024.109786

CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis

Fan Zhang, Dexian Wei, Shishun Xie, Liqun Ren, Sennan Qiao, Liying Li, Jiahua Ji, Zhimin Fan
PMCID: PMC11068616  PMID: 38706852

Main text

(iScience 27, 109057, 1–22; March 15, 2024)

In the original published version of this article, Figures 6E, 6F, S3E, and S3F are duplicates. Data from Figures 6E, 6F, S3E, and S3F were initially placed in the same figure and split during the revision process. During the revision process, an incorrect cell line was erroneously placed in Figures S3E and S3F. Thus, the corrected version of Figure S3 has been provided here, and the original article has been corrected online. The discussion and conclusions of this paper remain unchanged even after the corrections. The authors apologize for any inconvenience caused to the readers.

graphic file with name figs3o.jpg

Figure S3. MiR-1200 promotes malignant transformation in TNBC through TPR (original)

graphic file with name figs3c.jpg

Figure S3. MiR-1200 promotes malignant transformation in TNBC through TPR (corrected)


Articles from iScience are provided here courtesy of Elsevier

RESOURCES